Dimethyllysergamide
Systematic (IUPAC) name | |
---|---|
(6aR,9R)-N,N-dimethyl-7-methyl-4,6,6a,7,8,9- hexahydroindolo- [4,3-fg] quinoline- 9-carboxamide | |
Clinical data | |
Legal status |
|
Routes of administration | Oral |
Pharmacokinetic data | |
Metabolism | hepatic |
Excretion | renal |
Identifiers | |
PubChem | CID 199478 |
ChemSpider | 172668 |
Synonyms | DAM-57, Lysergic acid dimethylamide |
Chemical data | |
Formula | C18H21N3O |
Molar mass | 295.39 g/mol |
| |
| |
(verify) |
N,N-Dimethyllysergamide or N,N-dimethyl-D-lysergamide (DAM-57) is a derivative of ergine. There has been a single report of observing N,N-dimethyl-D-lysergamide in the illicit drug market.[1] This compound did induce autonomic disturbances at oral levels of some ten times the dosage required for LSD, presumably in the high hundreds of micrograms. There is some disagreement as to whether there were psychic changes observed.[2]
References
This article is issued from Wikipedia - version of the Friday, April 10, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.